Cart
sales@molnova.com
Cefoxitin sodium
CAS No. 33564-30-6
Cefoxitin sodium( Betacef | Cenomycin | Farmoxin | Mefoxin | Merxin )
Catalog No. M14139 CAS No. 33564-30-6
Cefoxitin sodium is a cephamycin antibiotic, often grouped with the second generation cephalosporins, acts by interfering with cell wall synthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 200MG | 36 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCefoxitin sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionCefoxitin sodium is a cephamycin antibiotic, often grouped with the second generation cephalosporins, acts by interfering with cell wall synthesis.
-
DescriptionCefoxitin sodium is a cephamycin antibiotic, often grouped with the second?generation cephalosporins, acts by interfering with cell wall synthesis, its activity spectrum includes a broad range of gram-negative and gram-positive bacteria.
-
In Vitro——
-
In Vivo——
-
SynonymsBetacef | Cenomycin | Farmoxin | Mefoxin | Merxin
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number33564-30-6
-
Formula Weight449.43
-
Molecular FormulaC16H16N3NaO7S2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 32mg/mL
-
SMILESCO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)CC3=CC=CS3.[Na+]
-
Chemical Namesodium;(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
SHIN1
SHIN1 is an inhibitor of human serine hydroxymethyltransferse 1(SHMT1) with IC50 of 5 nM and human serine hydroxymethyltransferse 2 (SHMT2) with an IC50 of 13 nM.
-
Vindesine sulfate
Vindesine sulfate is a vinca alkaloid which is a synthetic derivative of vinblastine, binds to the microtubular proteins of the mitotic spindle, leading to crystallization of the microtubule and mitotic arrest or cell death.
-
FIDAS-5
FIDAS-5 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding.?FIDAS-5 has anticancer activities.?FIDAS-5 is a potent and orally active methionine S-adenosyltransferase 2A (MAT2A) inhibitor with an IC50 of 2.1 μM.FIDAS-5 induces the expression of cell cycle inhibitor, p21WAF1/CIP1. FIDAS-5 (3 μM; 36 h) treatment reduces the levels of both S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in LS174T cells.FIDAS-5 (3 μM; 7 days; LS174T cells) treatment significantly inhibits the proliferation of LS174T cells.
